Mikkel Nissum

Title: Mikkel Nissum: Innovator in Diagnostic Methods

Introduction

Mikkel Nissum is a notable inventor based in Castellina in Chianti, Italy. He has made significant contributions to the field of diagnostics, particularly in methods related to diabetes and metabolic syndrome. With a total of 2 patents, Nissum's work is recognized for its innovative approach to medical technology.

Latest Patents

Nissum's latest patents include a method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition. This invention provides diagnostic in vitro methods, as well as kits and devices, for the diagnosis or prognosis of a pathologic condition characterized by the presence or absence of an endogenous hormone and/or hormone analogs involved in diabetes or metabolic syndrome. The methods involve a quantitative separation of analytes that may interfere with measuring the presence or concentration of other analytes of interest.

Another significant patent focuses on the use of MS-compatible nonionic or zwitterionic surfactants in free-flow electrophoresis. This invention allows for the separation of analytes with differentiated electrophoretic mobility, utilizing cleavable surfactants such as PPS.

Career Highlights

Mikkel Nissum is currently associated with Becton Dickinson and Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in enhancing diagnostic capabilities in the medical field.

Collaborations

Nissum has collaborated with notable colleagues, including Christoph Eckerskorn and Andreas Pfuetzner. These partnerships have contributed to the success of his innovative projects.

Conclusion

Mikkel Nissum's contributions to diagnostic methods reflect his commitment to improving healthcare through innovation. His patents demonstrate a forward-thinking approach that addresses critical health issues, making him a significant figure in the field of medical technology.